Feb. 24, 2012 11:40 UTC
DUBLIN--(BUSINESS WIRE)--
Research and Markets (http://www.researchandmarkets.com/research/3729ed/fragment_based_dru)
has announced the addition of Elsevier Science and Technology's new
report "Fragment
Based Drug Design. Tools, Practical Approaches, and Examples" to
their offering.
There are numerous excellent reviews on Fragment Based Drug Discovery
(FBDD), but there are to date no hand-holding guides or protocols with
which one can embark on this orthogonal approach to complement
traditional high throughput screening methodologies. This Methods in
Enzymology volume offers the tools, practical approaches, and
hit-to-lead examples on how to conduct FBDD screens. The chapters in
this volume cover methods that have proven to be successful in
generating leads from fragments, including chapters on how to apply
computational techniques, nuclear magnetic resonance, surface plasma
resonance, thermal shift and binding assays, protein crystallography,
and medicinal chemistry in FBDD. Also elaborated by experienced
researchers in FBDD are sample preparations of fragments, proteins, and
GPCR as well as examples of how to generate leads from hits.
Offers the tools, practical approaches, and hit-to-lead examples on how
to conduct FBDD screens. The chapters in this volume cover methods that
have proven to be successful in generating leads from fragments,
including chapters on how to apply computational techniques, nuclear
magnetic resonance, surface plasma resonance, thermal shift and binding
assays, protein crystallography, and medicinal chemistry in FBDD.
Key Topics Covered:
Part I. Tools
-
Designing a Diverse High Quality Library for Crystallography Based
FBDD Screening
-
Preparation of Protein Samples for NMR Structure, Function, and
Small-Molecule Screening Studies
-
Key Factors for Successful Generation of Protein-Fragment Structures:
Requirements on Protein, Crystals, and Technology
-
Automated Crystal Amplification and Compound Dispensation for FBDD
Analysis 5. Hardware and Protocols for Rapid Fragment Based Structure
Determination
-
Using Computational Techniques in Fragment-Based Drug Discovery
-
Computational Approaches to De Novo Discovery of Fragment Binding for
Unprecedented Protein States
Part II. Practical Approaches
-
How to Avoid Rediscovering the Known
-
From Experimental Design to Data Analysis: A Comprehensive
Walk-Through of Fragment Identification Using Surface Plasmon Resonance
-
Practical Aspects of NMR Based Fragment Screening
-
Fluorescent Protein Thermal Shifts to Identify Low Molecular Weight
Fragments
-
A HTS Reporter Displacement Assay for Fragment Screening and Fragment
Evolution Towards Leads with Optimized Binding Affinity, Binding
Kinetics, and Kinetic Selectivity
-
Fragment Screening of Stabilized G-Protein Coupled Receptors Using
Biophysical Methods
-
Predicting the Success of a Fragment Screening by X-Ray Crystallography
-
Fragment Screening Purely with Protein Crystallography
-
Structure Density Relationship Based FBDD
Part III. Lead Generation Examples
-
Lead Generation and Examples - Opinions Regarding How to Follow Up Hits
-
High Throughput Thermodynamics for Selection of Fragment Hits and
Guidance of Fragment Evolution
-
Medicinal Chemistry Inspired Fragment Based Drug Discovery
-
Experiences in Fragment-Based Lead Discovery
-
Advancing Fragment Binders to Lead Like Compounds Using Ligand and
Protein Based NMR Spectroscopy
-
Effective Progression of NMR-Directed Fragment Hits Hugh Eaton
-
Fragment Screening of Infectious Disease Targets in a Structural
Genomics Environment Douglas Davies
Author: Kuo, Lawrence C..
For more information visit http://www.researchandmarkets.com/research/3729ed/fragment_based_dru
